Cryptococcosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) No edit summary |
Sergekorjian (talk | contribs) |
||
| Line 18: | Line 18: | ||
===Age, Gender, and Race=== | ===Age, Gender, and Race=== | ||
Cryptococcosis has no age, gender, or race predilection.<ref name="cdc">C. neoformans Infection Statistics. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/fungal/diseases/cryptococcosis-neoformans/statistics.html Accessed on December 31, 2015</ref> | Cryptococcosis has no age, gender, or race predilection.<ref name="cdc">C. neoformans Infection Statistics. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/fungal/diseases/cryptococcosis-neoformans/statistics.html Accessed on December 31, 2015</ref> | ||
[[File:Cryptococcal_meningitis_in_africa.jpg|400px|left|thumb|Causes of death in sub-Saharan Africa, excluding HIV/AIDS. Adapted from BJ Park et al., AIDS 2009;23:525-530. <ref name=cdc>C. neoformans Infection Statistics. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/fungal/diseases/cryptococcosis-neoformans/statistics.html. Accessed on December 30, 2015.</ref>]] | |||
[[File:Cryptococcal_meningitis_world_burden.jpg|400px|none|thumb|The global burden of HIV-related cryptococcal meningitis. Adapted from BJ Park et al., AIDS 2009;23:525-530. <ref name=cdc>C. neoformans Infection Statistics. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/fungal/diseases/cryptococcosis-neoformans/statistics.html. Accessed on December 30, 2015.</ref>]] | |||
==References== | ==References== | ||
Revision as of 19:46, 20 January 2016
|
Cryptococcosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryptococcosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cryptococcosis epidemiology and demographics |
|
Risk calculators and risk factors for Cryptococcosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Serge Korjian M.D., Yazan Daaboul, M.D.
Overview
The prevalence of cryptococcal antigenemia among patients with HIV in the United States is approximately 2.9%. The overall incidence is estimated to be 0.4 to 1.3 cases per 100,000 population yearly in the United States. Cryptococcosis has no age, gender, or race predilection.[1]
Epidemiology and Demographics
Prevalence
- The prevalence of cryptococcal antigenemia in the general population is unknown. Given the low incidence in the general population, it is thought to be very low.
- Among HIV patients in the United States, the prevalence of cryptococcal antigenemia is approximately 2.9%, indicating that the prevalence of cryptococcal infection may be high enough to consider targeted screening for HIV patients.[1]
Incidence
- Nationally representative estimates for the incidence of cryptococcosis are difficult to establish because cryptococcosis is only reportable in a few states.
- Results from active, population-based surveillance in two US locations in the year 2000 indicated that the annual incidence of cryptococcosis among persons with AIDS was between 2 and 7 cases per 1,000
- The overall incidence is estimated to be 0.4 to 1.3 cases per 100,000 population yearly in the United States.
- C. neoformans is a major cause of illness in people living with HIV/AIDS, with an estimated 1 million cases of cryptococcal meningitis occurring worldwide each year.[1]
Age, Gender, and Race
Cryptococcosis has no age, gender, or race predilection.[1]
